Phase III Clinical Trials of UTD1 Injection Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced and Metastatic Breast Cancer
Phase of Trial: Phase III
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Depoxythilone (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Beijing Biostar Technologies
- 10 Feb 2017 Results published in the Lancet Oncology
- 07 Oct 2016 Status changed from active, no longer recruiting to completed.
- 07 Jun 2016 Primary endpoint (Progresssion free survival (PFS)) has been met according to the results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.